image
Aerovate Therapeutics, Inc. AVTE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.76
0.727 %
$ 80 M
Market Cap
-1.14
P/E
Price Target Average
552.17%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
25.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Aerovate Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for AVTE of $18 , with forecasts ranging from a low of $2 to a high of $65 .
AVTE Lowest Price Target Wall Street Target
2 USD -27.54%
AVTE Average Price Target Wall Street Target
18 USD 552.17%
AVTE Highest Price Target Wall Street Target
65 USD 2255.07%
Price
Max Price Target
Min Price Target
Average Price Target
707060605050404030302020101000Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart AVTE

image
$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart AVTE

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart AVTE

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)20232023202420242025202520262026202720272028202820292029